| CTRI Number |
CTRI/2024/02/063297 [Registered on: 29/02/2024] Trial Registered Prospectively |
| Last Modified On: |
20/02/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia Dentistry |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
CO2 Laser vs Traditional Scalpel for surgical management of oral precancerous lesions |
|
Scientific Title of Study
|
Comparative evaluation of CO2 Laser and traditional scalpel in the surgical management of oral potentially malignant disorder- A Randomized Controlled Trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Vartik Shah |
| Designation |
Post Graduate Student |
| Affiliation |
Government Dental College & Hospital, Nagpur |
| Address |
Department 106, Oral and Maxillofacial Surgery, Government Dental College & Hospital, Nagpur
Nagpur MAHARASHTRA 440003 India |
| Phone |
9930014736 |
| Fax |
|
| Email |
dr.vartik@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Abhay Datarkar |
| Designation |
Dean and Professor |
| Affiliation |
Government Dental College & Hospital, Nagpur |
| Address |
Department 106, Oral and Maxillofacial Surgery, Government Dental College & Hospital, Nagpur
Nagpur MAHARASHTRA 440003 India |
| Phone |
9930014736 |
| Fax |
|
| Email |
abhaydatarkar@yahoo.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Vartik Shah |
| Designation |
Post Graduate Student |
| Affiliation |
Government Dental College & Hospital, Nagpur |
| Address |
Department 106, Oral and Maxillofacial Surgery, Government Dental College & Hospital, Nagpur
Nagpur MAHARASHTRA 440003 India |
| Phone |
9930014736 |
| Fax |
|
| Email |
dr.vartik@gmail.com |
|
|
Source of Monetary or Material Support
|
| Government Dental College & Hospital, Nagpur |
|
|
Primary Sponsor
|
| Name |
Dr Vartik Shah |
| Address |
Department 106, Oral and Maxillofacial Surgery, Government Dental College and Hospital Nagpur |
| Type of Sponsor |
Other [Self Funded] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Vartik Shah |
Government Dental College and hospital Nagpur |
Department 106, Oral and Maxillofacial Surgery Nagpur MAHARASHTRA |
09930014736
dr.vartik@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Government Dental College & Hospital, Nagpur |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K132||Leukoplakia and other disturbancesof oral epithelium, including tongue, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Co2 Laser |
Use of Co2 laser for surgical management of oral potentially malignant disorder under necessary anaesthesia- surgery lasting upto maximum of 2 hours. Follow up taken till 2 weeks post operatively |
| Comparator Agent |
Traditional Scalpel |
Use of traditional scalpel for surgical management of oral potentially malignant disorder under necessary anaesthesia- surgery lasting upto maximum of 2 hours. Follow up taken till 2 weeks post operatively |
|
|
Inclusion Criteria
|
| Age From |
15.00 Year(s) |
| Age To |
75.00 Year(s) |
| Gender |
Both |
| Details |
1. All the patients reporting to department with oral potentially malignant disorders
2. Patients of age 15 years and above and below 75 years
3. Patients fit to undergo surgical excision under necessary anaesthesia
4. Patients with controlled blood sugar level
5. Patients with good general health status
|
|
| ExclusionCriteria |
| Details |
1. Patients with systemic immunocompromised conditions
2. Patients who are pregnant/ lactating mothers
3. Patients on steroids or oral contraceptives
4. Patients not fit to undergo surgical excision under necessary anaesthesia
5. Patients not willing to be a part of the study
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
|
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
1.Post-operative pain
2.Post operative swelling/edema
|
On the day of surgery, first and second week post operatively |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Ease of operability |
On the day of surgery |
| Intraoperative bleeding |
On the day of surgery |
| Post-operative scarring |
First and second week post operatively |
|
|
Target Sample Size
|
Total Sample Size="24" Sample Size from India="24"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
11/03/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report
- Who will be able to view these files?
Response - Researchers who provide a methodologically sound proposal.
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response - Proposals should be directed to [dr.vartik@gmail.com].
- For how long will this data be available start date provided 13-02-2025 and end date provided 11-03-2026?
Response (Others) -
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
Oral Potentially Malignant Diseases, abbreviated as OPMD, is
a term used to describe a number of oral mucosal conditions that have a higher
chance of developing cancer. Oral leukoplakia, erythroplakia,
erythroleukoplakia, oral submucous fibrosis (OSF), palatal lesions in reverse
smokers, and oral lichen planus are among the variety of OPMDs. Surgical
removal of the lesion (cold-knife, laser excision and vaporization,
cryosurgery, photodynamic therapy), medical treatment(topical or systemic),
cessation of risk activities and surveillance has been the standard care of
these lesions
CO2 laser was invented in 1964 by Kumar Patel. Since the
1970s, CO2 laser therapy has demonstrated to be a successful means of treating
patients with a variety of oral lesions. When combined with diligent clinical
follow-up, patient education to reduce risk factors, and reporting and
biopsying of any suspicious lesions, laser surgery for oral premalignant
disease has shown to be an efficient treatment option.
CO2 laser is considered to be the ideal laser and is very
useful in oral surgical procedures since the energy is maximally absorbed by
water in oral tissues. Cellular vaporisation occurs due to photothermal effect
which is the basis for tissue cutting by CO2 laser. The heat generated by the
laser raises the temperature within the target tissues above 100 ° C, which
results in the conversion of water into steam. As this causes instantaneous
vaporisation of intracellular fluid, it is thought that it may prevent the
release of chemical mediators of inflammation, and thereby reducing the acute
inflammatory response. A virtually bloodless field is created as blood vessels
with a lumen of less than 0.5 mm are sealed off with the laser
In comparison to scalpels, laser surgery has been found to
have a number of benefits. These benefits include less post-operative pain,
less scarring, and haemostasis. It also has the benefits of minimally affecting
nearby tissue, delaying the immediate inflammatory response, and reducing
myofibroblast activity, which reduces wound contraction and scarring. The
reduction in collagen production in post-operative phase maintains soft tissue
movement. It is also possible to leave the laser-treated region exposed to
granulate without the requirement for skin grafting or wound dressing. It is
also hypothesised that laser surgery causes less post-operative discomfort
This study is
planned in the department of oral and maxillofacial surgery to assess and
compare ease of operability and healing outcomes on the day of surgery, first
and second week post operatively following excision of OPMDs with CO2 laser
when compared to excision done with a scalpel and evaluating on the basis of
intraoperative time , intraoperative bleeding and post-operative pain, swelling
and scarring
PRIMARY RESEARCH QUESTION:
Whether CO2 Laser is
a valuable tool and better alternative to traditional scalpel for surgical
management of Oral Potentially Malignant Diseases
Primary Hypothesis- There is no statistically significant
difference in intraoperative bleeding, ease of operability and post-operative
pain, swelling and scarring between CO2 lasers and traditional scalpel when
used for surgical management of Oral Potentially Malignant Diseases
Alternate Hypothesis-There is statistically significant
difference in intraoperative bleeding, ease of operability and post-operative
pain, swelling and scarring between CO2 lasers and traditional scalpel when
used for surgical management of Oral Potentially Malignant Diseases |